Myocardial ischemia activates the JAK-STAT pathway through angiotensin II signaling in in vivo myocardium of rats

Journal of Molecular and Cellular Cardiology

Volumn 33, Issue 2, 2001, Pages 307-316

  Omura, Takashi ^a   Yoshiyama, Minoru ^a   Ishikura, Fuminobu ^b   Kobayashi, Haruka ^b   Takeuchi, Kazuhide ^a   Beppu, Sintaro ^b   Yoshikawa, Junichi ^a  

^a OSAKA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Angiotensin II; Janus kinase (JAK); Myocardial infarction; Signal transducer and activator of transcription (STAT); Sis inducing factor (SIF)

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 2 RECEPTOR; ANTIBODY; CANDESARTAN HEXETIL; DNA; IMIDAPRIL; JANUS KINASE; STAT PROTEIN; STAT1 PROTEIN; STAT3 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DNA BINDING; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; HEART MUSCLE ISCHEMIA; HEART VENTRICLE HYPERTROPHY; IMMUNOBLOTTING; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

JANUS; RATTUS NORVEGICUS;

EID: 0034972537     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.2000.1303     Document Type: Article

References (47)

1. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction
2. Global cardiac remodeling after acute myocardial infarction: A study in the rat model
3. Pathophysiology of congestive heart failure
4. Left ventricular remodeling after myocardial infarction: A corollary to infarct expansion
5. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease
6. Inhibition by angiotensin II type 1 receptor antagonist of cardiac phenotypic modulation after myocardial infarction
7. Growth hormone attenuates early left ventricular remodeling and improves cardiac function in rats with large myocardial infarction
8. Effects of enalapril on mortality in severe congestive heart failure
9. Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats
10. Activation of mitogen-activated protein kinases in in vivo ischemia/reperfused myocardium in rats
11. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes
12. Role of angiotensin II in activation of the JAK/STAT pathway induced by acute pressure overload in the rat heart
13. Biphasic activation of the JAK/STAT pathway by angiotensin II in rat cardiomyocytes
14. Experimental myocardial infarction in the rat: Qualitative and quantitative changes during pathologic evolution
15. Early and late effects of captopril treatment after large myocardial infarction in rats
16. Accuracy and feasibility of contrast echocardiography for detection of perfusion defects in routine practice: Comparison with wall motion and technetium-99m sestamibi single-photon emission computed tomography
17. Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells
18. Angiotensin blockade inhibits SIF DNA binding activities via STAT3 after myocardial infarction
19. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion
20. Alterations in cardiac gene expression during ventricular remodeling following experimental myocardial infarction
21. Transforming growth factor beta-1 in acute myocardial infarction in rats
22. Differences in expression of sarcoplasmic reticulum Ca2+-ATPase and Na+-Ca2+ exchanger genes between adjacent and remote non-infarcted myocardium after myocardial infarction
23. STATs: Signal transducers and activators of transcription
24. Identification of interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
25. The signaling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements
26. Transcriptional responses to polypeptide ligands: The JAK-STAT pathway
27. Two separate signal transducer and activators of transcription regulate transcription of the serine proteinase inhibitor-3 gene in hepatic cells
28. Continuous activation of gp130, a signal transducting receptor component for interleukin 6 related cytokines, causes myocardial hypertrophy in mice
29. Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes
30. Cardiotrophin-1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series VIA gp130/leukemia inhibitory factor receptor-dependent pathways
31. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure
32. Randomised trial of losartan versus captopril in patients over 65 with heart failure (Evaluation of Losartan in the Elderly Study, ELITE)
33. Effects of candesartan and cilazapril on myocardial infarcted rats assessed by echocardiography
34. Effects of an AT1 receptor antagonist, an ACE inhibitor and a calcium channel antagonist on cardiac gene expressions in hypertensive rats
35. Angiotensin II receptor antagonist TCV-116 induces regression of hypertensive left ventricular hypertrophy in vivo and inhibits the intracellular signaling pathway of stretch-mediated cardiomyocyte hypertrophy in vitro
36. Effect of ramipril and losartan on collagen expression in right and left heart after myocardial infarction
37. The type I angiotensin II receptor couples to Stat1 and Stat3 activation through Jak2 kinase in neonatal rat cardiac myocytes
38. Angiotensin II activates Stat5 through Jak2 kinase in cardiac myocytes
39. Relative effects of alpha 1-adrenoceptor blockade, converting enzyme inhibitor therapy, and angiotensin II subtype 1 receptor blockade on ventricular remodeling in the dog
40. Bradykinin antagonism inhibits the antigrowth effect of converting enzyme inhibition in the dog myocardium after discrete transmural myocardial necrosis
41. Preliminary biochemical characterization of two angiotensin II receptor subtypes
42. Pathophysiological role of angiotensin II type 2 receptor in cardiovascular and renal diseases
43. The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells
44. The subtype 2 (AT2) angiotensin receptor mediates renal production of nitric oxide in conscious rats
45. Coronary kinin generation mediates nitric oxide release after angiotensin receptor stimulation
46. Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR
47. Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists in rats with heart failure. Role of kinins and angiotensin II type 2 receptors